Artivila Therapeutics

About:

Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine.

Website: http://www.artivila.com

Top Investors: Highlight Capital, Hike Capital, Med-Fine Capital, Yijing Capital, Sinopharm Capital

Description:

Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform, providing first-in-class new molecules consistently and efficiently. Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.

Total Funding Amount:

250M CNY

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2018-01-01

Contact Email:

info(AT)artivilatx.com

Founders:

David Niu, Mike Zhu

Number of Employees:

11-50

Last Funding Date:

2022-03-31

IPO Status:

Private

© 2024 MyAiNote.com